I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

Her fake crocodile purse always contained the following: Dristan nasal spray, a $1 bill, a comb, Kleenex, a roll of Certs, a ...

In one of the most significant consumer-goods mergers of the year, Kimberly-Clark is buying Tylenol maker Kenvue in a ...

Aid, Huggies, and Kleenex are now under one roof. In a major business deal worth $48.7 billion, Kimberly-Clark, the company behind Huggies diapers and Kleenex tissues, is buying Kenvue, […] The post ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

US consumer goods giant Kimberly-Clark has agreed to acquire rival Kenvue in what will be one of the biggest takeovers of the ...

Kimberly-Clark to acquire Kenvue in a 48.7 billion deal, creating a consumer health giant with 32 billion in annual sales, facing market skepticism over pricing, leverage, and promised savings.

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...

Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, ...